Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Is expression of rat breast matrix components influenced by estrogen, progestins and tibolone?

Full text
Author(s):
Cunha, E. P. [1] ; Pompei, L. M. [1] ; Theodoro, T. R. [2] ; Steiner, M. L. [1] ; Silva, V. F. [3] ; Silveira, E. R. A. [3] ; Mader, A. M. A. A. [4] ; Pinhal, M. A. S. [2] ; Fernandes, C. E. [1]
Total Authors: 9
Affiliation:
[1] Fac Med ABC, Discipline Gynecol, Santo Andre - Brazil
[2] Fac Med ABC, Discipline Biochem, Santo Andre - Brazil
[3] Fac Med ABC, Santo Andre - Brazil
[4] Fac Med ABC, Discipline Pathol, Santo Andre - Brazil
Total Affiliations: 4
Document type: Journal article
Source: CLIMACTERIC; v. 18, n. 4, p. 523-527, AUG 2015.
Web of Science Citations: 0
Abstract

Aim To study the effects of estrogen therapy, alone or combined with progestogens, and of tibolone on the expression of heparanase (HSPE), extracellular matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9), perlecan and proliferating cell nuclear antigen (PCNA) in normal breast tissue. Methods Thirty 250-day-old Wistar rats were castrated and 3 weeks later received one of the following treatments by gavage for 5 weeks: (1) estradiol benzoate; (2) estradiol benzoate + medroxyprogesterone acetate; (3) estradiol benzoate + norethisterone acetate; (4) estradiol benzoate + dydrogesterone; (5) tibolone; (6) placebo. Following treatment, the expressions of mRNA for HSPE, MMP-2 and MMP-9 were analyzed by real-time PCR and the protein expressions of HSPE, MMP-2, MMP-9, perlecan and PCNA were quantified by immunohistochemistry. Results There was a statistically significant difference among the groups for the expression of HSPE mRNA due to high levels in the tibolone group. The groups differed in terms of PCNA, with lower levels found in the tibolone group followed by the estradiol benzoate + dydrogesterone group. A statistically significant positive correlation was observed for PCNA versus perlecan and MMP-9. Conclusions There was no difference in the effects of combinations of estradiol and different progestogens on extracellular matrix components, and breast cell proliferation was associated with increases in perlecan and MMP-9. (AU)

FAPESP's process: 11/13704-0 - Effect of tibolone, estradiol and estradiol combined with medroxyprogesterone acetate or norethindrone acetate or micronized progesterone in the presence of vascular matrix metalloproteinases and histomorphometric changes in breast tissue of rats
Grantee:Luciano de Melo Pompei
Support Opportunities: Regular Research Grants